TABLE 2.
Independent effects of baseline clinical risk factors on change in FEV1% predicted
| Full Model (R2 = 0.59) | 
Reduced Model (R2 = 0.56) | 
|||
| Baseline Risk Factor | ParamEst (SE) | P Value | ParamEst (SE) | P Value | 
| Age | −0.14 (0.07) | 0.06 | −0.16 (0.06) | 0.01 | 
| Gender (female) | 1.9 (0.4) | <0.01 | 1.8 (0.3) | <0.01 | 
| FEV1% predicted | 0.03 (0.01) | 0.04 | 0.03 (0.01) | 0.01 | 
| CF genotype (high risk)* | −0.01 (0.39) | 0.97 | ||
| BMI percentile | 0.01 (0.01) | 0.34 | ||
| Pseudomonas aeruginosa infection† | −0.26 (0.42) | 0.55 | ||
| Staphylococcus aureus infection† | −0.28 (0.42) | 0.51 | ||
Subjects were classified as having a “high risk” genotype if they had two identified class I, II or III CF mutations. Subjects with at least one class IV, V, or unidentified mutation were classified as having a “low risk” genotype.
Infection status was based on having a positive respiratory culture for P. aeruginosa or S. aureus during any of the four study visits.